San Diego-based mostly Viking Therapeutics marked alone as a serious competitor inside the weight loss drug market in February soon after revealing promising information from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied being a weekly injection As well as in March